Efficacy and Safety of PD-0332991 in Patients With Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib (CYCLIGIST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01907607
Recruitment Status : Active, not recruiting
First Posted : July 25, 2013
Last Update Posted : October 2, 2017
Information provided by (Responsible Party):
Institut Bergonié

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : April 2018
  Estimated Study Completion Date : April 2019